Combination targeted therapy provides durable remission for patients with CLL
A combination of ibrutinib and venetoclax was found to provide lasting disease remission in patients with newly diagnosed chronic lymphocytic
Read moreA combination of ibrutinib and venetoclax was found to provide lasting disease remission in patients with newly diagnosed chronic lymphocytic
Read morePARIS, March 31, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has approved Sarclisa (isatuximab-irfc) in combination with
Read morePRINCETON, N.J.–(BUSINESS WIRE) January 22, 2021– Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 240 mg (injection for
Read moreRenal cell carcinoma (RCC) is the most common form of kidney cancer. In 2018, there were an estimated 403,000 new
Read moreScientists have identified two drugs that are potent against acute myeloid leukemia (AML) when combined, but only weakly effective when
Read moreA team of researchers from the National University of Singapore (NUS) has utilized a ground-breaking artificial intelligence (AI) platform to
Read moreKENILWORTH, N.J.–(BUSINESS WIRE) November 13, 2020 — Merck (NYSE: MRK), known as MSD outside the United States and Canada, today
Read moreAdding an immunotherapy agent to a three-drug chemotherapy regimen can improve the likelihood that early-stage triple-negative breast cancer will recede
Read morePeople prefer coronavirus contact tracing to be carried out by a combination of apps and humans, a new study shows.
Read moreResults from a study of adults with kidney failure suggest that taking both short-acting benzodiazepines and opioids may put patients
Read more